Key Figures Q3 2003

Key Figures provide a succinct overview of the most significant developments for each period under review. You can view earlier quarters or years if you wish. Furthermore, you can find extensive reports by downloading press releases for the period of your choice.

Negative net result in Q3 (EUR 78 million) in line with announcement; considerable improvement of operating profit expected in Q4.

• Q3 2003 operating profit (EUR 26 million) shows very strong decrease due to lower net sales, margin squeezes for some business groups and one-off events.
• Net loss, due to extraordinary charge of EUR 102 million net in connection with restructuring measures, in line with announcement made on 1 October 2003.
• Acquisition of Roche Vitamins & Fine Chemicals (now DSM Nutritional Products) effected on 30 September.
• Outlook for Q4: DSM Nutritional Products’ operating profit at least EUR 25 million, representing an immediate contribution to EPS; considerable improvement in operating profit for rest of DSM compared with Q3 2003.